Planned phase IIb trial of ciclosporin for moderate to severe traumatic brain injuries.

Trial Profile

Planned phase IIb trial of ciclosporin for moderate to severe traumatic brain injuries.

Planning
Phase of Trial: Phase II

Latest Information Update: 21 Sep 2017

At a glance

  • Drugs Ciclosporin (Primary)
  • Indications Brain injuries
  • Focus Proof of concept; Registrational; Therapeutic Use
  • Sponsors NeuroVive Pharmaceutical
  • Most Recent Events

    • 21 Sep 2017 According to a NeuroVive Pharmaceutical AB media release, the EMA Scientific Advice feedback is supportive of the novel design of this trial.
    • 07 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top